Studies have also observed that the deficiency of HPSE reduces dendritic cell numbers in the lungs and selectively eliminates Th2 cell-mediated immune responses that induce asthma, providing potential new therapeutic targets for anti-inflammatory drugs to treat asthma and other allergic diseases (Poon et al., 2014). This evidence concerns the gene HPSE and allergic disease.